These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36813082)

  • 1. Curcumin, calebin A and chemosensitization: How are they linked to colorectal cancer?
    Brockmueller A; Samuel SM; Mazurakova A; Büsselberg D; Kubatka P; Shakibaei M
    Life Sci; 2023 Apr; 318():121504. PubMed ID: 36813082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calebin A Potentiates the Effect of 5-FU and TNF-β (Lymphotoxin α) against Human Colorectal Cancer Cells: Potential Role of NF-κB.
    Buhrmann C; Kunnumakkara AB; Popper B; Majeed M; Aggarwal BB; Shakibaei M
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence That Calebin A, a Component of
    Buhrmann C; Popper B; Kunnumakkara AB; Aggarwal BB; Shakibaei M
    Nutrients; 2019 Dec; 11(12):. PubMed ID: 31805741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-cancer activity of amorphous curcumin preparation in patient-derived colorectal cancer organoids.
    Elbadawy M; Hayashi K; Ayame H; Ishihara Y; Abugomaa A; Shibutani M; Hayashi SM; Hazama S; Takenouchi H; Nakajima M; Tsunedomi R; Suzuki N; Nagano H; Shinohara Y; Kaneda M; Yamawaki H; Usui T; Sasaki K
    Biomed Pharmacother; 2021 Oct; 142():112043. PubMed ID: 34411919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan.
    Fakhr E; Zare F; Azadmanesh K; Teimoori-Toolabi L
    Biomed Pharmacother; 2021 Nov; 143():112091. PubMed ID: 34474344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctionality of Calebin A in inflammation, chronic diseases and cancer.
    Brockmueller A; Mueller AL; Kunnumakkara AB; Aggarwal BB; Shakibaei M
    Front Oncol; 2022; 12():962066. PubMed ID: 36185259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.
    Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A
    Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin Synergizes with Cisplatin to Inhibit Colon Cancer through Targeting the MicroRNA-137-Glutaminase Axis.
    Fan WH; Wang FC; Jin Z; Zhu L; Zhang JX
    Curr Med Sci; 2022 Feb; 42(1):108-117. PubMed ID: 34958454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calebin A, a novel component of turmeric, suppresses NF-κB regulated cell survival and inflammatory gene products leading to inhibition of cell growth and chemosensitization.
    Tyagi AK; Prasad S; Majeed M; Aggarwal BB
    Phytomedicine; 2017 Oct; 34():171-181. PubMed ID: 28899500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA KCNQ1OT1 is a key factor in the reversal effect of curcumin on cisplatin resistance in the colorectal cancer cells.
    Zheng ZH; You HY; Feng YJ; Zhang ZT
    Mol Cell Biochem; 2021 Jul; 476(7):2575-2585. PubMed ID: 32757174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low curcumin concentration enhances the anticancer effect of 5-fluorouracil against colorectal cancer.
    Zheng X; Yang X; Lin J; Song F; Shao Y
    Phytomedicine; 2021 May; 85():153547. PubMed ID: 33812170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures.
    Shakibaei M; Buhrmann C; Kraehe P; Shayan P; Lueders C; Goel A
    PLoS One; 2014; 9(1):e85397. PubMed ID: 24404205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin attenuates resistance to irinotecan via induction of apoptosis of cancer stem cells in chemoresistant colon cancer cells.
    Su P; Yang Y; Wang G; Chen X; Ju Y
    Int J Oncol; 2018 Sep; 53(3):1343-1353. PubMed ID: 29956726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Influence of Curcumin on the Downregulation of MYC, Insulin and IGF-1 Receptors: A possible Mechanism Underlying the Anti-Growth and Anti-Migration in Chemoresistant Colorectal Cancer Cells.
    Hosseini SA; Zand H; Cheraghpour M
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987250
    [No Abstract]   [Full Text] [Related]  

  • 15. AKR1C4 regulates the sensitivity of colorectal cancer cells to chemotherapy through ferroptosis modulation.
    Wang L; Lv C; Liu X
    Cancer Chemother Pharmacol; 2024 Sep; 94(3):373-385. PubMed ID: 38890190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcuma as an adjuvant in colorectal cancer treatment.
    Villegas C; Perez R; Sterner O; González-Chavarría I; Paz C
    Life Sci; 2021 Dec; 286():120043. PubMed ID: 34637800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.
    Igarashi H; Taniguchi H; Nosho K; Ishigami K; Koide H; Mitsuhashi K; Okita K; Takemasa I; Imai K; Nakase H
    Clin Transl Oncol; 2020 Jul; 22(7):1126-1137. PubMed ID: 31741141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of NF-κB and Src protein kinase signaling pathways.
    Shakibaei M; Mobasheri A; Lueders C; Busch F; Shayan P; Goel A
    PLoS One; 2013; 8(2):e57218. PubMed ID: 23451189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
    Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
    Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.